Intravesical Bcg

DRUG2 trials

Sponsors

Mansoura University, Insel Gruppe AG, University Hospital Bern

Conditions

Bladder CancerNMIBC

Unknown Phase

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Mansoura UniversityBladder Cancer

Start: 2021-12-01End: 2023-01-01Target: 110Updated: 2022-01-11

Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study

CompletedNCT07798479

Insel Gruppe AG, University Hospital BernBladder Cancer, NMIBC

Start: 2009-03-01End: 2024-05-31Updated: 2026-09-01